Building a future-ready business means having a team ready to take on the challenges of tomorrow. But managing the complexities of today’s workforce demands that...
Have you ever thought that you’d like to help early stage companies grow but you don’t know enough about the process? Or that you’d like...
Join Marcum LLP and Troutman Pepper for this webinar which will discuss market trends and developments offering lenders and borrowers pertinent tips for debt financing...
Come join us at the ‘tee’ for an afternoon of golf and networking. We start the afternoon with a golf clinic by Lyman’s PGA and...
Join us at this information session to learn first hand about the ABCT 2023 programs. Ask your questions in a virtual format. Hear about the...
It’s been one year since the passage of the IRA. The Centers for Medicare & Medicaid Services has moved forward implementing the law’s various provisions, including the new Medicare negotiation program and the redesign of the Medicare Part D benefit. Learn the latest developments from our panel of experts, including how the IRA is impacting biopharmaceutical companies today. Panelists will delve into other important issues beyond the IRA, including new developments in Medicaid, 340B, and the emergence of Prescription Drug Affordability Boards in a number of states.
Moderator:
John Murphy, Chief Policy Officer, BIO
Speakers:
Crystal Kuntz, SVP, Health Policy & Reimbursement, BIO
Erin Hertzog, Partner, Foley Hoag LLP
Jim Meyers, Senior Advisor, BCG